Literature DB >> 7961976

Characterization of the regulatory elements in the promoter of the human elongation factor-1 alpha gene.

N Wakabayashi-Ito1, S Nagata.   

Abstract

Most eukaryotic cells abundantly express polypeptide chain elongation factor-1 alpha (EF-1 alpha), an enzyme which catalyzes the GTP-dependent binding of aminoacyl-tRNA to ribosomes. In this study, a series of deletion and scanning mutations was introduced in the promoter region of human EF-1 alpha chromosomal gene. Mutated promoters were fused to the bacterial chloramphenicol acetyltransferase gene, and their promoter activity was determined in human HeLa cells. These analyses indicated that both the 5'-flanking region and the first intron of the EF-1 alpha gene are essential for its promoter activity. The region responsible in the intron contains several Sp1 and Ap1 elements which seem to have additive effects on its promoter activity. In the 5'-flanking region, two cis-elements (EFP1 and EFP2) which work interdependently were identified. Gel shift assay with EFP1 and EFP2 elements indicated that several nuclear factors bind to EFP1 and EFP2, and one of the three retarded bands with EFP2 could be super-shifted with the anti-Sp1 antibody. These results indicate that Sp1 or its related factor cooperatively enhances the expression of the EF-1 alpha gene in the 5' flanking region.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7961976

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Promoter-associated RNA is required for RNA-directed transcriptional gene silencing in human cells.

Authors:  Jiang Han; Daniel Kim; Kevin V Morris
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-17       Impact factor: 11.205

2.  Regulation of elongation factor-1 expression by vitamin E in diabetic rat kidneys.

Authors:  May Al-Maghrebi; Constantin Cojocel; Mary S Thompson
Journal:  Mol Cell Biochem       Date:  2005-05       Impact factor: 3.396

3.  Production of Trichoderma reesei cellulases on glucose-containing media.

Authors:  T Nakari-Setälä; M Penttilä
Journal:  Appl Environ Microbiol       Date:  1995-10       Impact factor: 4.792

4.  miR-29b supplementation decreases expression of matrix proteins and improves alveolarization in mice exposed to maternal inflammation and neonatal hyperoxia.

Authors:  Shaheen Durrani-Kolarik; Caylie A Pool; Ashley Gray; Kathryn M Heyob; Mary J Cismowski; Gloria Pryhuber; L James Lee; Zhaogang Yang; Trent E Tipple; Lynette K Rogers
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-05-04       Impact factor: 5.464

5.  MicroRNA-29 overexpression by adeno-associated virus suppresses fibrosis and restores muscle function in combination with micro-dystrophin.

Authors:  Kristin N Heller; Joshua T Mendell; Jerry R Mendell; Louise R Rodino-Klapac
Journal:  JCI Insight       Date:  2017-05-04

6.  Constitutive modulation of Raf-1 protein kinase is associated with differential gene expression of several known and unknown genes.

Authors:  S Patel; F H Wang; T L Whiteside; U Kasid
Journal:  Mol Med       Date:  1997-10       Impact factor: 6.354

Review 7.  Expression of Exogenous Genes in Murine Primary B Cells and B Cell Lines Using Retroviral Vectors.

Authors:  Zhiyong Yang; Christopher D C Allen
Journal:  Methods Mol Biol       Date:  2018

8.  Different Sp1 family members differentially affect transcription from the human elongation factor 1 A-1 gene promoter.

Authors:  S J Nielsen; M Praestegaard; H F Jorgensen; B F Clark
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

9.  Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model.

Authors:  Janaiah Kota; Raghu R Chivukula; Kathryn A O'Donnell; Erik A Wentzel; Chrystal L Montgomery; Hun-Way Hwang; Tsung-Cheng Chang; Perumal Vivekanandan; Michael Torbenson; K Reed Clark; Jerry R Mendell; Joshua T Mendell
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

10.  O-linked N-acetylglucosaminylation of Sp1 inhibits the human immunodeficiency virus type 1 promoter.

Authors:  Ramona Jochmann; Mathias Thurau; Susan Jung; Christian Hofmann; Elisabeth Naschberger; Elisabeth Kremmer; Thomas Harrer; Matthew Miller; Niels Schaft; Michael Stürzl
Journal:  J Virol       Date:  2009-02-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.